Antibacterial

Clazamycin A
Catalog No: CFN00247

Clazamycin A is a novel pyrrolizidine antitumor antibiotic.

Clazamycin B
Catalog No: CFN00248

Clazamycin B is a novel pyrrolizidine antitumor antibiotic.

Moronic acid
Catalog No: CFN97145

Moronic acid shows oral therapeutic efficacy in HSV-infected mice and possessed novel anti-HSV activity. It also shows significant anti-HIV activity (EC(50) 186) and was modified to develop more potent anti-AIDS agents. Moronic acid is a new structural lead for anti-EBV drug development, can substantially reduce the numbers of EBV particles produced by the cells after lytic induction. Morolic and moronic acids have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an insulin sensitization with consequent changes of glucose, cholesterol and triglycerides, in part mediated by inhibition of 11β-HSD 1 as indicated by in vitro.

Cabraleadiol
Catalog No: CFN97147

Cabraleadiol displays antimycobacterial activity against Mycobacterium tuberculosis, it also is weakly cytotoxic to a breast cancer (BC) cell line. Cabraleadiol inhibits photosystem II (PS II) and induces the appearance of small G band which is related with the decreased plastoquinone (PQ) pool reduction.

Rediocide C
Catalog No: CFN97156

Rediocide C exhibits antimycobacterial activity, with the MIC value of 3.84 uM; it also exhibits potent activity against D. pteronyssinus with respective LC50 values of 5.59 microg/cm2.